… To illustrate this high heterogeneity of natural histories in pituitary carcinomas, we will
depict two clinical presentations of patients with a final diagnosis of pituitary carcinoma, who …

… Aggressive pituitary tumors (APTs) and pituitary carcinomas (PCs) are heterogeneous with
regard to clinical presentation, proliferative markers, clinical course, and response to therapy. …

… However, the exact incidence of both aggressive pituitary adenomas and pituitary carcinomas
is unknown, as most data come from series with selected patients, such as surgically …

… Aggressive pituitary tumors (APT) refer to pituitary adenomas … an unusually rapid tumor
growth rate, or clinically relevant tumor growth … of the previous term ‘atypical pituitary adenoma’. …

… to change the term “adenoma” to “tumor” [4]. A study involving an exceptionally large cohort
of 125 aggressive pituitary tumors (APT) and 40 pituitary carcinomas (PC) showed that APT …

… to an invasive pituitary tumor. Compared to non-aggressive pituitary adenomas transcranial
… In the presence of a pituitary carcinoma even more aggressive surgical treatment and the …

… option for pituitary carcinomas and aggressive pituitary tumors. … in pituitary carcinomas
and aggressive pituitary tumors, … of tumor-infiltrating lymphocytes in anterior pituitary tumors, …

… aggressive pituitary adenomas and which clinical markers can help in the diagnosis of these
tumors… Temozolomide therapy in patients with aggressive pituitary adenomas or carcinomas…

… A second patient survey was developed by the ESE taskforce on Aggressive Pituitary
Tumours/Carcinomas and made available from August 2020 to the participants of the ESE 2015–…

… After temozolomide failure, no evidence-based treatment option is currently available for
aggressive pituitary tumors (APTs) and pituitary carcinomas (PCs). Moreover, once …